246 related articles for article (PubMed ID: 27676126)
1. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.
Kageyama Y; Kasahara T; Morishita H; Mataga N; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Inoue K; Kato T
Psychiatry Clin Neurosci; 2017 Feb; 71(2):115-123. PubMed ID: 27676126
[TBL] [Abstract][Full Text] [Related]
2. Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study.
Kageyama Y; Kasahara T; Nakamura T; Hattori K; Deguchi Y; Tani M; Kuroda K; Yoshida S; Goto YI; Inoue K; Kato T
Int J Neuropsychopharmacol; 2018 Mar; 21(3):207-215. PubMed ID: 29040586
[TBL] [Abstract][Full Text] [Related]
3. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
[TBL] [Abstract][Full Text] [Related]
4. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis.
Girshkin L; Matheson SL; Shepherd AM; Green MJ
Psychoneuroendocrinology; 2014 Nov; 49():187-206. PubMed ID: 25108162
[TBL] [Abstract][Full Text] [Related]
5. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
Kunz M; Gama CS; Andreazza AC; Salvador M; Ceresér KM; Gomes FA; Belmonte-de-Abreu PS; Berk M; Kapczinski F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1677-81. PubMed ID: 18657586
[TBL] [Abstract][Full Text] [Related]
7. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
8. Towards a blood-based diagnostic panel for bipolar disorder.
Haenisch F; Cooper JD; Reif A; Kittel-Schneider S; Steiner J; Leweke FM; Rothermundt M; van Beveren NJM; Crespo-Facorro B; Niebuhr DW; Cowan DN; Weber NS; Yolken RH; Penninx BWJH; Bahn S
Brain Behav Immun; 2016 Feb; 52():49-57. PubMed ID: 26441135
[TBL] [Abstract][Full Text] [Related]
9. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder.
Tasic L; Larcerda ALT; Pontes JGM; da Costa TBBC; Nani JV; Martins LG; Santos LA; Nunes MFQ; Adelino MPM; Pedrini M; Cordeiro Q; Bachion de Santana F; Poppi RJ; Brietzke E; Hayashi MAF
J Psychiatr Res; 2019 Dec; 119():67-75. PubMed ID: 31568986
[TBL] [Abstract][Full Text] [Related]
10. 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.
Xu XJ; Zheng P; Ren GP; Liu ML; Mu J; Guo J; Cao D; Liu Z; Meng HQ; Xie P
Mol Biosyst; 2014 Apr; 10(4):813-9. PubMed ID: 24457555
[TBL] [Abstract][Full Text] [Related]
11. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.
Raffa M; Barhoumi S; Atig F; Fendri C; Kerkeni A; Mechri A
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):371-5. PubMed ID: 22841966
[TBL] [Abstract][Full Text] [Related]
12. Decreased plasma levels of neureglin-1 in drug naïve patients and chronic patients with schizophrenia.
Wang R; Wang Y; Hu R; Chen X; Song M; Wang X
Neurosci Lett; 2015 Oct; 606():220-4. PubMed ID: 26365407
[TBL] [Abstract][Full Text] [Related]
13. Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from Bipolar Disorder.
Kumar CT; Christodoulou T; Vyas NS; Kyriakopoulos M; Corrigall R; Reichenberg A; Frangou S
Schizophr Res; 2010 Dec; 124(1-3):152-60. PubMed ID: 20674278
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of schizoaffective disorder compared with schizophrenia and bipolar disorder.
Pagel T; Baldessarini RJ; Franklin J; Baethge C
Acta Psychiatr Scand; 2013 Oct; 128(4):238-50. PubMed ID: 23465195
[TBL] [Abstract][Full Text] [Related]
15. Can P300 distinguish among schizophrenia, schizoaffective and bipolar I disorders? An ERP study of response inhibition.
Chun J; Karam ZN; Marzinzik F; Kamali M; O'Donnell L; Tso IF; Manschreck TC; McInnis M; Deldin PJ
Schizophr Res; 2013 Dec; 151(1-3):175-84. PubMed ID: 24210871
[TBL] [Abstract][Full Text] [Related]
16. Global DNA hypomethylation and its correlation to the betaine level in peripheral blood of patients with schizophrenia.
Murata Y; Ikegame T; Koike S; Saito T; Ikeda M; Sasaki T; Iwata N; Kasai K; Bundo M; Iwamoto K
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109855. PubMed ID: 31911076
[TBL] [Abstract][Full Text] [Related]
17. The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression.
Kageyama Y; Kasahara T; Kato M; Sakai S; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Goto Y; Kinoshita T; Inoue K; Kato T
J Affect Disord; 2018 Jun; 233():15-20. PubMed ID: 28633757
[TBL] [Abstract][Full Text] [Related]
18. Assessment of a multi-assay biological diagnostic test for mood disorders in a Japanese population.
Yamamori H; Ishima T; Yasuda Y; Fujimoto M; Kudo N; Ohi K; Hashimoto K; Takeda M; Hashimoto R
Neurosci Lett; 2016 Jan; 612():167-171. PubMed ID: 26687272
[TBL] [Abstract][Full Text] [Related]
19. Bipolar disorder and schizophrenia share a similar deficit in semantic inhibition: a meta-analysis based on Hayling Sentence Completion Test performance.
Wang K; Song LL; Cheung EF; Lui SS; Shum DH; Chan RC
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():153-60. PubMed ID: 23886783
[TBL] [Abstract][Full Text] [Related]
20. Relationships between corpus callosum and language lateralization in patients with schizophrenia and bipolar disorders.
Tréhout M; Leroux E; Delcroix N; Dollfus S
Bipolar Disord; 2017 Sep; 19(6):496-504. PubMed ID: 28834020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
